Structured evidence table for Milk Thistle Cardiometabolic Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Milk Thistle Cardiometabolic Randomized Trial | Gut microbiota modulation was associated with improved sleep patterns, quality-of-life perception, cytokines expression, and anthropometric parameters post-supplementation. | 2 | Santamarina AB (2024) | Nutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial. |
| Milk Thistle Cardiometabolic Randomized Trial | Nutraceutical interventions supporting microbiota and eliciting clinical improvements in metabolic diseases have grown significantly. | 2 | Santamarina AB (2024) | Nutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial. |
| Milk Thistle Cardiometabolic Randomized Trial | Chronic stress, gut dysbiosis, and metainflammation have emerged as key factors intertwined with sleep disorders, consequently exacerbating the decline in quality of life. | 2 | Santamarina AB (2024) | Nutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial. |
| Milk Thistle Cardiometabolic Randomized Trial | Material and methods We consecutively enrolled 80 mildly hypercholesterolemic patients with low-density lipoprotein-cholesterol (LDL-C) between 130 and 190 mg/dl with a low-estimated cardiovascular disease risk. | 2 | Fogacci F (2023) | Effect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study. |
| Milk Thistle Cardiometabolic Randomized Trial | Introduction The scientific community and consumers are increasingly interested in the potential cholesterol-lowering effect of various nutraceuticals and their combinations. | 2 | Fogacci F (2023) | Effect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study. |
| Milk Thistle Cardiometabolic Randomized Trial | The aim of our study was to test the short-term effect of a new lipid-lowering nutraceutical formulation in mildly hypercholesterolemic patients. | 2 | Fogacci F (2023) | Effect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study. |
Source documents